ACTIMED THERAPEUTICS LTD

🏛️Establishedactive
10519588 · ltd · incorporated 2016-12-09
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
Why now
Window opening · medium confidence
More negotiable than before — 1 signals weakening over the last 30 days.
  • · Hygiene score: 90 → 85
What changed my view
Last 30 days

Picture worsened over the last 30 days — 1 negative signal vs 0 positive.

  • Hygiene score: 9085
Last 90 days

No snapshot from 90 days ago — start tracking from today.

Last 180 days

No snapshot from 180 days ago — start tracking from today.

🔒Estimated value
Upgrade to see
Turnover
not disclosed
Net worth
book net assets
Opportunity
76/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pursue
Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 76/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: medium (55/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
No iXBRL financials extracted
0
Lenders & charges
Confirmed no charges registered
85
Directors & officers
10 officers (7 active, 10 linked, 9 with DOB)
88
Ownership & PSC
0 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
154 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
76/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Recent activity

Last 30 days
4
filings
  • 2 capital
  • 2 officers
Last 90 days
6
filings
  • 4 capital
  • 2 officers
Last 180 days
10
filings
  • 5 capital
  • 2 officers
  • 1 miscellaneous
Counts from Companies House filing history.
Corporate timeline (37 events)Click to expand
  1. 2026-07-22
    📄
    capital-allotment-shares
    capital · SH01
  2. 2026-07-21
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  3. 2026-07-17
    📄
    capital-allotment-shares
    capital · SH01
  4. 2026-07-16
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  5. 2026-07-01
    ULLMAN, Sven Anders appointed
    director
  6. 2026-06-30
    WOHLFEIL, Stefan, Dr. resigned
    director
  7. 2026-06-19
    📄
    capital-allotment-shares
    capital · SH01
  8. 2026-05-12
    📄
    capital-allotment-shares
    capital · SH01
  9. 2026-04-21
    📄
    legacy
    miscellaneous · RP01SH01
  10. 2026-04-01
    📄
    capital-allotment-shares
    capital · SH01
  11. 2026-03-12
    📄
    resolution
    resolution · RESOLUTIONS
  12. 2025-11-04
    📄
    capital-allotment-shares
    capital · SH01
  13. 2025-09-18
    📄
    accounts-with-accounts-type-small
    accounts · AA
  14. 2025-09-09
    📄
    capital-allotment-shares
    capital · SH01
  15. 2025-07-31
    📄
    capital-allotment-shares
    capital · SH01
  16. 2025-07-15
    📄
    capital-allotment-shares
    capital · SH01
  17. 2025-06-25
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  18. 2025-06-23
    📄
    capital-allotment-shares
    capital · SH01
  19. 2025-06-17
    📄
    resolution
    resolution · RESOLUTIONS
  20. 2025-06-17
    📄
    memorandum-articles
    incorporation · MA
  21. 2025-06-13
    MISSELWITZ, Frank Johannes Paul resigned
    director
  22. 2024-12-27
    📄
    capital-allotment-shares
    capital · SH01
  23. 2024-12-23
    📄
    resolution
    resolution · RESOLUTIONS
  24. 2024-12-17
    📄
    capital-allotment-shares
    capital · SH01
  25. 2024-12-16
    📄
    resolution
    resolution · RESOLUTIONS
  26. 2024-12-06
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  27. 2024-10-24
    ANKER, Stefan, Professor appointed
    director
  28. 2023-01-24
    MAJUMDAR, Atish appointed
    director
  29. 2019-08-31
    PARKIN, Glyn Robert resigned
    director
  30. 2019-08-15
    BHATTACHERJEE, Robin Chandra appointed
    director
  31. 2019-05-02
    WOHLFEIL, Stefan, Dr. appointed
    director
  32. 2018-01-05
    EBSWORTH, David Raymond appointed
    director
  33. 2018-01-05
    MISSELWITZ, Frank Johannes Paul appointed
    director
  34. 2017-12-28
    JACKSON, Hugh appointed
    secretary
  35. 2017-11-16
    PARKIN, Glyn Robert appointed
    director
  36. 2016-12-09
    🏢
    Company incorporated
    As ACTIMED THERAPEUTICS LTD
  37. 2016-12-09
    COATS, Andrew Justin Stewart, Prof appointed
    director

Owner dependency

55/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • -6 active directors: Broader management team in place — suggests transferable governance.
  • +Founder age: Director aged approximately 72 — succession pressure is live.

Succession & seller-readiness

60/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 70+: Senior director is approximately 72 years old. Natural succession window is now.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Similar companies

Active · Professional services · SL postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
ALOIS TECHNOLOGIES LIMITED
10621417 · est 2017 · no financials extracted
9y
ANDY ZMH LTD
16811942 · est 2025 · no financials extracted
ANGLO AUSTRIAN LIMITED
12980013 · est 2020 · no financials extracted
5y
ANJA BIO LTD
14841576 · est 2023 · no financials extracted
2y
ANTROBUS SOLUTIONS LIMITED
11755491 · est 2019 · no financials extracted
7y
ANUSHIA REDDY LIMITED
10274045 · est 2016 · no financials extracted
9y
APEX SALES PERFORMANCE LTD
16172747 · est 2025 · no financials extracted
1y
APOGEE PROCUREMENT LIMITED
11257686 · est 2018 · no financials extracted
8y
APPLEDOWN CLINICAL RESEARCH LIMITED
03886155 · est 1999 · no financials extracted
26y
APPLIED LEGAL SERVICES LIMITED
10720275 · est 2017 · no financials extracted
9y
APPRENTICESHIP SOLUTIONS LIMITED
07771979 · est 2011 · no financials extracted
14y
APPTITUDE COACHING & CONSULTING LIMITED
17120977 · est 2026 · no financials extracted
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2016-12-09
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

The Old Bakehouse
Course Road
Ascot
Berkshire
SL5 7HL
England

Filing status

Accounts
Next due: 2026-09-30
Last made up to: 2024-12-31
Confirmation statement
Next due: 2027-01-24
Last: 2026-01-10

Officers (7 active · 3 resigned)

JACKSON, Hugh
secretary · appointed 2017-12-28
View their other companies + combined net worth →
Active
ANKER, Stefan, Professor
director · ~61y · appointed 2024-10-24
View their other companies + combined net worth →
Active
BHATTACHERJEE, Robin Chandra
director · ~64y · appointed 2019-08-15
View their other companies + combined net worth →
Active
COATS, Andrew Justin Stewart, Prof
director · ~68y · appointed 2016-12-09
View their other companies + combined net worth →
Active
EBSWORTH, David Raymond
director · ~72y · appointed 2018-01-05
View their other companies + combined net worth →
Active
MAJUMDAR, Atish
director · ~53y · appointed 2023-01-24
View their other companies + combined net worth →
Active
ULLMAN, Sven Anders
director · ~70y · appointed 2026-07-01
View their other companies + combined net worth →
Active
MISSELWITZ, Frank Johannes Paul
director · ~70y · appointed 2018-01-05 · resigned 2025-06-13
Resigned
PARKIN, Glyn Robert
director · ~75y · appointed 2017-11-16 · resigned 2019-08-31
Resigned
WOHLFEIL, Stefan, Dr.
director · ~70y · appointed 2019-05-02 · resigned 2026-06-30
Resigned

Click a director name to see their full track record across all companies.

Recent filings (154 total)

capital-allotment-shares
capital · SH01
2026-07-22
appoint-person-director-company-with-name-date
officers · AP01
2026-07-21
capital-allotment-shares
capital · SH01
2026-07-17
termination-director-company-with-name-termination-date
officers · TM01
2026-07-16
capital-allotment-shares
capital · SH01
2026-06-19
capital-allotment-shares
capital · SH01
2026-05-12
legacy
miscellaneous · RP01SH01
2026-04-21
capital-allotment-shares
capital · SH01
2026-04-01
resolution
resolution · RESOLUTIONS
2026-03-12
confirmation-statement-with-updates
confirmation-statement · CS01
2026-03-10
capital-allotment-shares
capital · SH01
2025-11-04
accounts-with-accounts-type-small
accounts · AA
2025-09-18
capital-allotment-shares
capital · SH01
2025-09-09
capital-allotment-shares
capital · SH01
2025-07-31
capital-allotment-shares
capital · SH01
2025-07-15